XML 47 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summaries of Recognized and Unrecognized Stock-Based Compensation Expense

Below are summaries of the recognized and unrecognized stock-based compensation expense by instrument for the periods indicated:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

(In thousands)

 

Recognized compensation expense:

 

 

 

 

 

 

 

 

 

 

 

 

Options

 

$

71

 

 

$

70

 

 

$

331

 

 

$

74

 

RSAs

 

 

1,001

 

 

 

603

 

 

 

2,509

 

 

 

1,776

 

PSUs

 

 

959

 

 

 

768

 

 

 

2,814

 

 

 

2,072

 

ESPP

 

 

123

 

 

 

133

 

 

 

499

 

 

 

588

 

Total recognized compensation expense

 

$

2,154

 

 

$

1,574

 

 

$

6,153

 

 

$

4,510

 

 

 

 

September 30, 2025

 

 

 

(In thousands)

 

Unrecognized compensation expense:

 

 

 

Options

 

$

125

 

RSAs

 

 

6,691

 

PSUs

 

 

4,151

 

ESPP

 

 

102

 

Total unrecognized compensation expense

 

$

11,069

 

Weighted average period expected to be recognized (in years)

 

 

 

Options

 

 

2.0

 

RSAs

 

 

2.2

 

Summary of Stock Option Activity

The table below summarizes stock option activity for the nine months ended September 30, 2025 and 2024:

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

 

($ in thousands, except per share amounts)

 

Number of shares:

 

 

 

 

 

 

Options outstanding at beginning of period

 

 

1,065,772

 

 

 

752,964

 

Granted

 

 

4,740

 

 

 

83,359

 

Modified

 

 

(283,790

)

 

 

 

Options outstanding at end of period

 

 

786,722

 

 

 

836,323

 

Options exercisable at end of period

 

 

759,115

 

 

 

749,321

 

Options expected to vest (1)

 

 

27,607

 

 

 

87,002

 

Weighted average exercise price per share:

 

 

 

 

 

 

Options outstanding at beginning of period

 

$

14.46

 

 

$

12.88

 

Granted

 

 

17.50

 

 

 

18.23

 

Modified

 

 

18.23

 

 

 

 

Options outstanding at end of period

 

$

13.12

 

 

$

13.41

 

Options exercisable at end of period

 

 

12.94

 

 

 

12.88

 

Options expected to vest (1)

 

 

18.11

 

 

 

17.95

 

Aggregate intrinsic value (2):

 

 

 

 

 

 

Options outstanding at end of period

 

$

4,041

 

 

$

5,183

 

Options exercisable at end of period

 

 

4,025

 

 

 

5,039

 

Options expected to vest (1)

 

 

16

 

 

 

144

 

Weighted average remaining contractual life (in years):

 

 

 

 

 

 

Options outstanding at end of period

 

 

4.5

 

 

 

5.8

 

Options exercisable at end of period

 

 

4.4

 

 

 

5.3

 

Options expected to vest (1)

 

 

9.0

 

 

 

9.8

 

(1)
The number of options expected to vest reflects no expected forfeiture.
(2)
The aggregate intrinsic value represents the amount by which the fair value of underlying stock exceeds the “in-the-money” option exercise price.
Summary of Restricted Stock Award Activities

The table below summarizes RSA activity for the nine months ended September 30, 2025 and 2024:

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

 

Employee

 

 

Non-Employee Director

 

 

Total

 

 

Employee

 

 

Non-Employee Director

 

 

Total

 

Number of shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unvested at beginning of period

 

 

355,505

 

 

 

47,430

 

 

 

402,935

 

 

 

409,137

 

 

 

61,276

 

 

 

470,413

 

Granted

 

 

329,495

 

 

 

17,292

 

 

 

346,787

 

 

 

195,164

 

 

 

15,939

 

 

 

211,103

 

Vested

 

 

(190,522

)

 

 

(26,261

)

 

 

(216,783

)

 

 

(248,796

)

 

 

(29,785

)

 

 

(278,581

)

Unvested at end of period

 

 

494,478

 

 

 

38,461

 

 

 

532,939

 

 

 

355,505

 

 

 

47,430

 

 

 

402,935

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average grant date fair value per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unvested at beginning of period

 

$

13.52

 

 

$

12.03

 

 

$

13.35

 

 

$

9.39

 

 

$

9.31

 

 

$

9.38

 

Granted

 

 

18.78

 

 

 

16.48

 

 

 

18.66

 

 

 

15.93

 

 

 

17.88

 

 

 

16.08

 

Vested

 

 

13.73

 

 

 

10.85

 

 

 

13.38

 

 

 

8.61

 

 

 

9.57

 

 

 

8.71

 

Unvested at end of period

 

$

16.95

 

 

$

14.83

 

 

$

16.79

 

 

$

13.52

 

 

$

12.03

 

 

$

13.35

 

 

Summary of Performance Stock Units Activities

The table below summarizes PSU activity for the nine months ended September 30, 2025 and 2024:

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value Per Share

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value Per Share

 

Outstanding at beginning of period, unvested

 

 

517,131

 

 

$

12.83

 

 

 

256,387

 

 

$

11.05

 

Granted (1)

 

 

155,165

 

 

 

18.82

 

 

 

157,994

 

 

 

15.86

 

Performance adjustment

 

 

153,637

 

 

 

10.00

 

 

 

102,750

 

 

 

12.63

 

Vested

 

 

(205,500

)

 

 

12.63

 

 

 

 

 

 

 

Outstanding at end of period, unvested

 

 

620,433

 

 

$

13.69

 

 

 

517,131

 

 

$

12.83

 

(1)
The number of PSUs are presented at 100% of the specified target shares.